 |
2002 |
||||||
|
Browse Archives
n Lung n Breast n General n Prostate n Leukemia n Lymphoma n Colon n Cervical/Uteri n Ovarian n Pancreatic n News/Issues |
Int'l study finds higher risk of cancer in Hodgkin's survivors BETHESDA, MD. -- Aug. 15, 2002 -- Long-term survivors of Hodgkin's disease, an immune system cancer, have double the normal risk of developing a subsequent cancer later in life a new international study shows. Cat study links cigarette smoke to feline lymphoma NORTH GRAFTON, MASS. -- July 29, 2002 (Cancer Digest) -- Cats living in homes where people smoke cigarettes are more than twice as likely as other cats to acquire a deadly form of cancer known as feline lymphoma, according to veterinarian scientists. Gene test could point to curable lymphoma BETHESDA, Md. -- June 18, 2002 (Cancer Digest) -- Genetic tests may be able to predict which patients with the most common form of lymphoma will be cured with chemotherapy, researchers report in today's New England Journal of Medicine. Antibody 'truck' delivers radiation directly to cancer ROCHESTER, MINN. -- May 14, 2002 -- A new study shows that the first of a new class of drugs using an antibody to deliver radiation directly to cancer cells in patients with low-grade B cell non-Hodgkin's lymphoma may be more effective than a similar drug that uses an antibody without radiation. Researchers test custom-made vaccine BALTIMORE -- April 25, 2002 (Cancer Digest) -- Researchers hope to cure cancer patients with a form of lymphoma using a vaccine tailor-made from each patient's own tumor cells. Monkey virus found in human lymphoma samples HOUSTON-- Mar. 9, 2002 (Cancer Digest)-- Scientists in a pair of studies released today have discovered genetic evidence of a monkey virus contained in a significant number of non-Hodgkin's lymphoma samples. New lymphoma drug approach gets FDA approval SAN DIEGO -- Feb 19, 2002 (Cancer Digest) -- The FDA today recommended approval of a new drug that delivers radiation to individual non-Hodgkin's Lymphoma cells in patients who have become resistant to another drug called Rituxan. New drug combo boosts survival of non-Hodgkin's lymphoma BASEL, SWITZERLAND, 24 Jan. 2002 -- The standard chemotherapy combined with the drug rituximab produced the most significant survival gain in two decades for patients with a common type of lymphoma, a European study shows. Chemo-radiation improves early-stage Hodgkin's disease SEATTLE -- 13 Nov. 2001 -- A short course of chemotherapy followed by radiation significantly improves time to disease progression and minimizes toxicity in patients with early-stage Hodgkin's disease, according to a large United States multi-center trial. FDA panel backs new drug for non-Hodgkin's Lymphoma BETHESDA, Md. -- Sept. 11, 2001 (Cancer Digest)-- An advisory panel for the FDA today recommended approval of a new drug that delivers radiation to individual non-Hodgkin's Lymphoma cells in patients who have become resistant to another drug called Rituxan. Common virus may make Hodgkin's Disease more aggressive SEATTLE -- Apr. 19, 2001 (cancerfacts.com) -- The virus that caused the "kissing disease" may make a form of blood cancer more aggressive in older women, say researchers in a new study. Virus linked to spread of breast cancer and lymphoma ANN ARBOR, MI - Feb. 28, 2001 -- Scientists have found a link between the virus that causes the "kissing disease" and aggressive forms of breast and immune system cancers. |
||||||
SUBSCRIBE
FREE